secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2025-06-18T23:59:59+00:00
Accession:  0001641172-25-015654
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa prices $7M public offering of common stock and warrants at $0.25/unit
------------------------------------------------------------------------------

- Gross proceeds of $7M before expenses; offering of 28M shares/pre-funded warrants plus 28M common warrants.
- Combined price $0.25 per share (or pre-funded warrant) and accompanying common warrant.
- Common warrants exercisable at $0.25/share for 5 years, immediately exercisable.
- Net proceeds to fund Phase 2 trial of NGC-Cap and for working capital & general corporate purposes.
- H.C. Wainwright acted as placement agent; receives 7% cash fee and 1.12M Placement Agent Warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000164117225015654/0001641172-25-015654-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000164117225015654/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-015654

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer